KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Payables (2016 - 2026)

Medpace Holdings filings provide 12 years of Payables readings, the most recent being $34.4 million for Q1 2026.

  • On a quarterly basis, Payables fell 43.85% to $34.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $34.4 million, a 43.85% decrease, with the full-year FY2025 number at $28.1 million, down 13.48% from a year prior.
  • Payables hit $34.4 million in Q1 2026 for Medpace Holdings, up from $28.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $278.5 million in Q2 2022 to a low of $24.4 million in Q1 2024.
  • Median Payables over the past 5 years was $32.5 million (2024), compared with a mean of $68.3 million.
  • Biggest five-year swings in Payables: skyrocketed 1093.95% in 2022 and later plummeted 83.96% in 2024.
  • Medpace Holdings' Payables stood at $83.1 million in 2022, then plummeted by 61.64% to $31.9 million in 2023, then grew by 2.07% to $32.5 million in 2024, then dropped by 13.48% to $28.1 million in 2025, then grew by 22.34% to $34.4 million in 2026.
  • The last three reported values for Payables were $34.4 million (Q1 2026), $28.1 million (Q4 2025), and $26.5 million (Q3 2025) per Business Quant data.